Marico acquires Derma Rx through its subsidiary

Marico has acquired aesthetics business of the Singapore based Derma Rx Asia Pacific (Derma Rx), through its wholly owned subsidiary Kaya.

The deal, for an undisclosed consideration, envisages the acquisition by Derma Rx International Aesthetics, a wholly owned subsidiary of Kaya, of the Intellectual Property Rights (IPRs) relating to DermaRx’s business and the shares in wholly owned subsidiaries of Derma Rx Asia Pacific.

The said acquisition provides Kaya access to an advanced range of skin care products and a strong sourcing network, including suppliers of products from developed nations.

The company also plans to introduce, over time, Derma Rx products into its range of offerings, at Kaya clinics in India and the Middle East. This would enable Kaya to increase its share of revenue, from sale of products, from the current level of about 13% to over 20%.

Kaya delivers skin care solutions, in India and overseas, through its range of Kaya Skin Clinics.